← Open Payments lookup

KAMERYN FEVELLA: Open Payments

NPI 1003316423 · SAINT FRANCISVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$897 in 63 payments from 15 companies in 2025. Trend: 2023 $836 · 2024 $657 · 2025 $897

Food & beverage: $897
CompanyPaymentsAmount
ABBVIE INC.21$190
Novo Nordisk Inc11$148
GlaxoSmithKline, LLC.8$145
PFIZER INC.6$104
Phathom Pharmaceuticals, Inc.5$48
Bayer Healthcare Pharmaceuticals Inc.2$42
Organon LLC2$38
Regeneron Healthcare Solutions, Inc.1$31
Boston Scientific Corporation1$27
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25

Products named: VRAYLAR, TRELEGY ELLIPTA, ELIQUIS, Wegovy, VOQUEZNA, Ozempic, Rybelsus, Kerendia.

Industry payments across LA — which companies pay providers there.